Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Lymphoma 1 Leukemia 1

Interventions

Cyclophosphamide 260 fludarabine phosphate 163 Methotrexate 124 Rituximab 112 Cytarabine 109 Filgrastim 106 fludarabine 92 Busulfan 86 Peripheral Blood Stem Cell Transplantation 83 Etoposide 82 Vincristine 80 Radiotherapy 79 Tacrolimus 73 Mycophenolic Acid 72 Antilymphocyte Serum 68 Whole-Body Irradiation 66 Melphalan 63 Dexamethasone 63 Cyclosporine 58 Doxorubicin 51 Methylprednisolone 44 Alemtuzumab 44 Prednisone 43 Mercaptopurine 40 Granulocyte Colony-Stimulating Factor 40 pegaspargase 35 Daunorubicin 34 Clofarabine 33 Thiotepa 31 Asparaginase 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia × Clozapine × Lymphoid × Clear all

NCT04074213 2019-08-30

CLOZARIX

University Hospital, Caen

1,000,000 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡